Try the Demo today!
| SEC Filing | Company/Stock | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Gain/Loss |
|---|---|---|---|---|---|---|---|---|
| 05-Jan-22 7:14 PM View:  | Keros Therapeutics, Inc. (KROS) | 05-Jan-22 | Market Sale (Planned) | 4,034 | $58.25 | $234,991.00 | (< 1%) 578.34K to 574.3K | (< 1%) |
| 05-Jan-22 7:14 PM View: | Keros Therapeutics, Inc. (KROS) | 04-Jan-22 | Market Sale (Planned) | 20,062 | $57.55 | $1,154,670.00 | (3%) 598.4K to 578.34K | (2%) |
| 05-Jan-22 7:14 PM View: | Keros Therapeutics, Inc. (KROS) | 03-Jan-22 | Market Sale (Planned) | 23,555 | $58.01 | $1,366,460.00 | (4%) 621.95K to 598.4K | (1%) |
| 03-Dec-21 5:05 PM View: | Keros Therapeutics, Inc. (KROS) | 02-Dec-21 | Market Sale (Planned) | 25,338 | $53.57 | $1,357,380.00 | (4%) 647.29K to 621.95K | (1%) |
| 03-Dec-21 5:05 PM View: | Keros Therapeutics, Inc. (KROS) | 01-Dec-21 | Market Sale (Planned) | 22,313 | $54.68 | $1,219,990.00 | (3%) 669.6K to 647.29K | < 1% |
| 03-Nov-21 7:04 PM View: | Keros Therapeutics, Inc. (KROS) | 03-Nov-21 | Market Sale (Planned) | 15,967 | $41.95 | $669,780.00 | (2%) 685.57K to 669.6K | (1%) |
| 03-Nov-21 7:04 PM View: | Keros Therapeutics, Inc. (KROS) | 02-Nov-21 | Market Sale (Planned) | 7,881 | $42.40 | $334,149.00 | (1%) 693.45K to 685.57K | < 1% |
| 03-Nov-21 7:04 PM View: | Keros Therapeutics, Inc. (KROS) | 01-Nov-21 | Market Sale (Planned) | 23,803 | $42.15 | $1,003,200.00 | (3%) 717.25K to 693.45K | (< 1%) |
| 21-Oct-21 4:29 PM View: | Keros Therapeutics, Inc. (KROS) | 20-Oct-21 | Market Sale (Planned) | 4,082 | $38.24 | $156,095.00 | (< 1%) 721.34K to 717.25K | < 1% |
| 21-Oct-21 4:29 PM View: | Keros Therapeutics, Inc. (KROS) | 19-Oct-21 | Market Sale (Planned) | 4,516 | $38.16 | $172,346.00 | (< 1%) 725.85K to 721.34K | < 1% |
| 18-Oct-21 8:35 PM View: | Keros Therapeutics, Inc. (KROS) | 18-Oct-21 | Market Sale (Planned) | 13,786 | $37.70 | $519,711.00 | (2%) 739.64K to 725.85K | (3%) |
| 18-Oct-21 8:35 PM View: | Keros Therapeutics, Inc. (KROS) | 15-Oct-21 | Market Sale (Planned) | 8,198 | $39.16 | $321,052.00 | (1%) 747.84K to 739.64K | < 1% |
| 18-Oct-21 8:35 PM View: | Keros Therapeutics, Inc. (KROS) | 14-Oct-21 | Market Sale (Planned) | 4,383 | $40.13 | $175,890.00 | (< 1%) 752.22K to 747.84K | 3% |
| 05-Oct-21 8:47 PM View: | Keros Therapeutics, Inc. (KROS) | 05-Oct-21 | Market Sale (Planned) | 2,617 | $40.03 | $104,759.00 | (< 1%) 754.84K to 752.22K | 2% |
| 05-Oct-21 8:47 PM View: | Keros Therapeutics, Inc. (KROS) | 04-Oct-21 | Market Sale (Planned) | 3,746 | $40.06 | $150,065.00 | (< 1%) 758.58K to 754.84K | 2% |
| 05-Oct-21 8:47 PM View: | Keros Therapeutics, Inc. (KROS) | 01-Oct-21 | Market Sale (Planned) | 6,323 | $40.16 | $253,932.00 | (< 1%) 764.9K to 758.58K | 2% |
| 29-Sep-21 4:39 PM View: | Keros Therapeutics, Inc. (KROS) | 27-Sep-21 | Market Sale (Planned) | 95,302 | $41.17 | $3,924,000.00 | (11%) 860.21K to 764.9K | < 1% |
| 06-Jul-21 10:00 PM View: | Keros Therapeutics, Inc. (KROS) | 02-Jul-21 | Market Sale (Planned) | 23,818 | $41.34 | $984,565.00 | (3%) 884.02K to 860.21K | 3% |
| 06-Jul-21 10:00 PM View: | Keros Therapeutics, Inc. (KROS) | 01-Jul-21 | Market Sale (Planned) | 23,834 | $41.28 | $983,787.00 | (3%) 907.86K to 884.02K | 2% |
| 08-Jun-21 4:31 PM View: | Keros Therapeutics, Inc. (KROS) | 07-Jun-21 | Market Sale (Planned) | 12,796 | $49.89 | $638,451.00 | (1%) 920.65K to 907.86K | (1%) |
| 08-Jun-21 4:31 PM View: | Keros Therapeutics, Inc. (KROS) | 04-Jun-21 | Market Sale (Planned) | 6,619 | $47.46 | $314,162.00 | (< 1%) 927.27K to 920.65K | (7%) |
| 03-Jun-21 8:06 PM View: | Keros Therapeutics, Inc. (KROS) | 03-Jun-21 | Market Sale (Planned) | 7,895 | $47.97 | $378,730.00 | (< 1%) 935.17K to 927.27K | (1%) |
| 03-Jun-21 8:06 PM View: | Keros Therapeutics, Inc. (KROS) | 02-Jun-21 | Market Sale (Planned) | 11,529 | $48.76 | $562,138.00 | (1%) 946.7K to 935.17K | < 1% |
| 03-Jun-21 8:06 PM View: | Keros Therapeutics, Inc. (KROS) | 01-Jun-21 | Market Sale (Planned) | 8,812 | $52.51 | $462,686.00 | (< 1%) 955.51K to 946.7K | 8% |
| 05-May-21 5:22 PM View: | Keros Therapeutics, Inc. (KROS) | 04-May-21 | Market Sale (Planned) | 2,835 | $53.92 | $152,857.00 | (< 1%) 958.35K to 955.51K | (< 1%) |
| 05-May-21 5:22 PM View: | Keros Therapeutics, Inc. (KROS) | 03-May-21 | Market Sale (Planned) | 44,816 | $57.48 | $2,575,990.00 | (4%) 1.0M to 958.35K | 5% |
| 08-Apr-21 4:35 PM View: | Keros Therapeutics, Inc. (KROS) | 06-Apr-21 | Market Sale (Planned) | 9,298 | $58.81 | $546,840.00 | (< 1%) 1.01M to 1.0M | (4%) |
| 05-Apr-21 9:11 PM View: | Keros Therapeutics, Inc. (KROS) | 05-Apr-21 | Market Sale (Planned) | 27,151 | $60.07 | $1,630,830.00 | (3%) 1.04M to 1.01M | 2% |
| 05-Apr-21 9:11 PM View: | Keros Therapeutics, Inc. (KROS) | 01-Apr-21 | Market Sale (Planned) | 11,202 | $58.89 | $659,704.00 | (1%) 1.05M to 1.04M | < 1% |
| 05-Mar-21 7:44 PM View: | Keros Therapeutics, Inc. (KROS) | 04-Mar-21 | Market Sale (Planned) | 11,632 | $55.48 | $645,385.00 | (1%) 1.06M to 1.05M | < 1% |
| 05-Mar-21 7:44 PM View: | Keros Therapeutics, Inc. (KROS) | 03-Mar-21 | Market Sale (Planned) | 12,327 | $57.36 | $707,115.00 | (1%) 1.07M to 1.06M | 4% |
| 03-Mar-21 8:40 PM View: | Keros Therapeutics, Inc. (KROS) | 02-Mar-21 | Market Sale (Planned) | 10,711 | $58.75 | $629,285.00 | (< 1%) 1.09M to 1.07M | 2% |
| 03-Mar-21 8:40 PM View: | Keros Therapeutics, Inc. (KROS) | 01-Mar-21 | Market Sale (Planned) | 12,979 | $63.09 | $818,793.00 | (1%) 1.1M to 1.09M | 9% |
| 18-Feb-21 6:46 PM View: | Keros Therapeutics, Inc. (KROS) | 18-Feb-21 | Market Sale (Planned) | 2,944 | $63.11 | $185,785.00 | (< 1%) 1.1M to 1.1M | 1% |
| 18-Feb-21 6:46 PM View: | Keros Therapeutics, Inc. (KROS) | 17-Feb-21 | Market Sale (Planned) | 16,061 | $61.05 | $980,588.00 | (1%) 1.12M to 1.1M | (2%) |
| 18-Feb-21 6:46 PM View: | Keros Therapeutics, Inc. (KROS) | 16-Feb-21 | Market Sale (Planned) | 9,612 | $59.89 | $575,671.00 | (< 1%) 1.13M to 1.12M | (4%) |
| 16-Feb-21 5:50 PM View: | Keros Therapeutics, Inc. (KROS) | 12-Feb-21 | Market Sale (Planned) | 7,468 | $61.53 | $459,495.00 | (< 1%) 1.13M to 1.13M | 2% |
| 16-Feb-21 5:50 PM View: | Keros Therapeutics, Inc. (KROS) | 11-Feb-21 | Market Sale (Planned) | 11,561 | $64.82 | $749,441.00 | (1%) 1.15M to 1.13M | 7% |
| 13-Apr-20 5:13 PM View: | Keros Therapeutics, Inc. (KROS) | 13-Apr-20 | Conversion | 915,725 | -- | -- | 397% 230.38K to 1.15M | |
| 20-Jan-23 4:32 PM View: | Keros Therapeutics, Inc. (KROS) | 13-Apr-20 | Purchase | 1,191 | $20.98 | $24,987.20 | < 1% 574.3K to 575.49K |